IFN confirms participation at in-cosmetics Global 2026, presenting its R&D and mass-production strength in synthetic biology protein ingredients to European and global buyers, accelerating global supply of Type III collagen and other innovative ingredients.
2026-06-20
IFN Confirms Participation at in-cosmetics Global 2026
Going global, showcasing China's synthetic biology protein strength to worldwide buyers.
Powiązane aktualności
2026-09-18
Type III Humanized Recombinant Collagen Achieves 80°C+ Thermal Stability
IFN research institute breaks 80°C thermal stability, redefining industry standards.
2026-08-26
China's First Fibronectin Medical Device Raw Material Master File Completed
IFN fibronectin becomes China's first filed medical device raw material master file of its kind.
2026-07-10
IFN to Exhibit Type III Collagen at PCHi 2026
At the global cosmetic ingredients event PCHi 2026, IFN showcases its full recombinant protein range.